Clinical trial
A Study About the Impact of Intensive Instruction on the Use of Aricept and the Reasons for Discontinuation in Patients With Alzheimer's Disease
NCT01972204 is registered in ClinicalTrials.gov with Mirai Iryo Research Center, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study About the Impact of Intensive Instruction on the Use of Aricept and the Reasons for Discontinuation in Patients With Alzheimer's Disease
- Lead sponsor
- Mirai Iryo Research Center, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2013
- Completion date
- August 31, 2017
- Enrollment
- 125 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer's type dementia